Both in Surgical Instruments
Nephros vs Daxor
Over the past year NEPH returned −40.4% and DXR returned −21.5%; their daily moves had a correlation of 0.00.
NEPH −40.4% DXR −21.5%Growth of $1, one year, split-adjusted
| Metric | NEPH | DXR |
|---|---|---|
| Price | $3.23 | $8.99 |
| Market cap | $35.1M | $52.5M |
| Today | −7.98% | +1.12% |
| 1 month | −17.0% | −23.2% |
| 6 months | −0.3% | −15.6% |
| Year to date | −33.8% | −39.1% |
| 1 year | −40.4% | — |
| Revenue growth (YoY) | +36.2% | +2.3% |
| Gross margin | 66.9% | 52.2% |
| Net margin | 19.9% | −403.2% |
| P/E (TTM) | 20.2× | — |
| Price / sales | 1.7× | — |
| Net cash | $4.7M | $18.7M |
| Dividend yield | — | — |
| Volatility (60d) | 78.8% | 42.5% |
| Short % of float | 0.2% | 0.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).